Literature DB >> 22323960

A case report of anesthesia management in the liver transplantation recipient with porphyria -A case report-.

Hye Won Song1, Young Hee Shin, Justin Sangwook Ko, Mi Sook Gwak, Gaab Soo Kim.   

Abstract

Porphyrias are a group of diseases characterized by an enzyme deficiency in the heme biosynthesis pathway, resulting in accumulation of precursor molecules in the tissue. Some porphyric patients develop progressive liver disease that requires liver transplantation. This case report describes special anesthetic challenges, including careful selection of drugs and the use of special filters that can exclude harmful wavelengths of ultraviolet, in a patient with porphyria who underwent living donor liver transplantation. Understanding the patient's status and disease process, and avoiding triggering factors of porphyria attacks, are important for successful liver transplantation anesthesia in patients with porphyria.

Entities:  

Keywords:  Filters; Liver transplantation; Porphyria

Year:  2012        PMID: 22323960      PMCID: PMC3272535          DOI: 10.4097/kjae.2012.62.1.83

Source DB:  PubMed          Journal:  Korean J Anesthesiol        ISSN: 2005-6419


  14 in total

1.  Uneventful propofol anesthesia in a patient with coexisting hereditary coproporphyria and hereditary angioneurotic edema.

Authors:  C D Sarantopoulos; N C Bratanow; D F Stowe; J P Kampine
Journal:  Anesthesiology       Date:  2000-02       Impact factor: 7.892

Review 2.  Porphyrias.

Authors:  M F James; R J Hift
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

3.  Remifentanil and acute intermittent porphyria.

Authors:  M Durmus; A Turkoz; T Togal; A Koroglu; H I Toprak; M O Ersoy
Journal:  Eur J Anaesthesiol       Date:  2002-11       Impact factor: 4.330

4.  Recovery from a variegate porphyria by a liver transplantation.

Authors:  Nathalie Stojeba; Carole Meyer; Catherine Jeanpierre; Frédéric Perrot; Christine Hirth; Thierry Pottecher; Jean-Charles Deybach
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

5.  Prolonged loss of consciousness and elevated porphyrins following propofol administrations.

Authors:  S J Asirvatham; T W Johnson; M P Oberoi; W M Jackman
Journal:  Anesthesiology       Date:  1998-10       Impact factor: 7.892

6.  Drugs in the acute porphyrias--toxicogenetic diseases.

Authors:  M R Moore; R J Hift
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1997-02       Impact factor: 1.770

Review 7.  Anesthetic considerations in porphyrias.

Authors:  N F Jensen; D S Fiddler; V Striepe
Journal:  Anesth Analg       Date:  1995-03       Impact factor: 5.108

8.  Anaesthetic management of a patient with erythropoietic protoporphyria for ventricular septal defect closure.

Authors:  B Asokumar; C Kierney; T W James; J Amato; K J Tumanmd
Journal:  Paediatr Anaesth       Date:  1999       Impact factor: 2.556

9.  Porphyrinogenic effects of atracurium, vecuronium, and pancuronium in a primed rat model.

Authors:  H Böhrer; H Schmidt; A Bach; E Martin; B Kohl; K Bolsen; G Goerz
Journal:  Lab Anim Sci       Date:  1994-08

10.  Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria.

Authors:  Staffan Wahlin; Nirthiga Srikanthan; Børge Hamre; Pauline Harper; Atle Brun
Journal:  Liver Transpl       Date:  2008-09       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.